1) Alexopoulos GS, Meyers BS, Young RC, et al:"Vascular depression" hypothesis. Arch Gen Psychiatry 54:915-922, 1997
2) Baba H, Kubota Y, Suzuki T, et al:Seven cases of late-life depression treated with cilostazol-augmented therapy. J Clin Psychopharmacol 27:727-728, 2007
3) de Asis JM, Greenwald BS, Alexopoulos GS, et al:Frontal signal hyperintensities in mania in old age. Am J Geriatr Psychiatry 14:598-604, 2006
4) Devanand DP, Adorno E, Cheng J, et al:Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients. J Affect Disord 78:259-267, 2004
5) Folstein MF, Maiberger R, McHugh PR:Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry 40:1018-1020, 1977
6) 藤倉由季,馬場元,大久保拓,他:Cilostazolが奏効した老年期うつ病の2症例,精神医学 48:1101-1107,2006
7) Fujikawa T, Yamawaki S, Touhouda Y:Incidence of silent cerebral infarction in patients with major depression. Stroke 24:1631-1634, 1993
8) Fujikawa T, Yamawaki S, Touhouda Y:Silent cerebral infarctions in patients with late-onset mania. Stroke 26:946-949 1995
9) Herrmann LL, Le Masurier M, Ebmeier KP:White matter hyperintensities in late life depression:A systematic review. J Neurol Neurosurg Psychiatry 79:619-624, 2008
10) Krishnan KR, Goli V, Ellinwood EH:Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry 23:519-522, 1988
11) Krishnan KR, Hays JC, Blazer DG, et al:MRI-defined vascular depression. Am J Psychiatry 154:497-501, 1997
12) Mochizuki Y, Oishi M, Mizutani T:Effects of cilostazol on cerebral blood flow, P300, and serum lipid levels in the chronic stage of cerebral infarction. J Stroke Cerebrovasc Dis 10:63-69, 2000
13) Oishi M, Mochizuki Y, Shikata E, et al:Effect of cilostazol on cerebral blood flows in chronic stage of cerebral circulation. Keio J Med 49:145-147, 2000
14) Robinson RG:Mood Disorders Secondary to Stroke. Semin Clin Neuropsychiatry 2:244-251, 1997
15) Steffens DC, Krishnan KR:Structural neuroimaging and mood disorders:Recent findings, implications for classification, and future directions. Biol Psychiatry 43:705-712, 1998
16) Subramaniam H, Dennis MS, Byrne EJ:The role of vascular risk factors in late onset bipolar disorder. Int J Geriatr Psychiatry 22:733-737, 2007
17) Takahashi K, Oshima A, Inoue K, et al:Novel augmentation therapy with cilostazol for the geriatric major depressive disorder patient with deep white matter hyperintensities on T2-weighted brain MRI:A case report. Pharmacopsychiatry 41:37-39, 2008
18) Tamashiro JH, Zung S, Zanetti MV, et al:Increased rates of white matter hyperintensities in late-onset bipolar disorder. Bipolar Disord 10:765-775, 2008
19) Watanabe T, Zhang N, Liu M, et al:Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke 37:1539-1545, 2006